Figures & data
Table 1 Patients’ Characteristics at Baseline and the Comparison Between the PI and SC Groups
Table 2 Comparison of the Reasons for Donepezil Discontinuation Between the PI and SC Groups (FAS)
Table 3 Association Between Donepezil Continuation and Clinical Variables at Baseline (FAS)
Table 4 Summary of Safety Assessments (SAS)